CompletedNCT00686933
What is this study about?Researchers studied ABT-089, tracking side effects to assess long-term safety and tolerability in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including LafayetteADHDMedication studyAges 18–60
- Countries
- United States
- Sponsor
- AbbVie (prior sponsor, Abbott)
CompletedNCT00269815
What is this study about?Researchers studied methylphenidate HCl to find out how it affected sleep difficulties in children with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 6–13
- Countries
- Sponsor
- Alza Corporation, DE, USA
CompletedNCT00508677
Official study titleMazindol in Children With Attention Deficit Hyperactivity Disorder Design Study to Explore the Effectiveness, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Orally Administered Doses of Mazindol.
This study has finished and is no longer accepting participants.
In ParisADHDObservational studyAges 6–12
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
CompletedNCT03252522
Official study titleEvaluating the Efficacy of Supplementation With Micronutrients for ADHD in Youth (MADDY) Study
This study has finished and is no longer accepting participants.
Multiple locations, including ColumbusADHDPlacebo comparisonAges 6–12
- Countries
- United States, Canada
- Sponsor
- Oregon Health and Science University
CompletedNCT01968512
Official study titleNeurobiological Aspects of the Attention Deficit Hyperactivity Disorder: Contribution of the Transcranial Direct Current Stimulation in Control Inhibitory.
This study has finished and is no longer accepting participants.
In SalvadorADHDDevice studyAges 18–60
- Countries
- Brazil
- Sponsor
- Federal University of Bahia
CompletedNCT00416091
Official study titleNeuropsychological Functioning, Symptomatology, and Social Adjustment Among Children With Tourret's Disorder, Attention-Deficit/Hyperactivity Disorder, and Comorbid Conditions.
This study has finished and is no longer accepting participants.
In TaipeiADHDObservational studyAges 8–16
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT00874536
Official study titleThe Effect of Omega-3 Fatty Acid Supplementation on Behavior of Children With ADHD
This study has finished and is no longer accepting participants.
In JerusalemADHDPlacebo comparisonAges 6–16
- Countries
- Israel
- Sponsor
- Hadassah Medical Organization
CompletedNCT01338818
Official study titleA 6-month, Open-label Extension to a 40-week, Randomized, Double-blind, Placebo-controlled, Multicenter Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in the Treatment of Adult Patients With Childhood-onset ADHD
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 18–60
- Countries
- United States, Belgium, Colombia, + 3 others
- Sponsor
- Novartis Pharmaceuticals
CompletedNCT01176136
Official study titleOrganizational Skills Interventions for Children With ADHD
This study has finished and is no longer accepting participants.
In CincinnatiADHDBehavioural studyAges 11–15
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
CompletedNCT03610464
Official study titlePharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years With Attention-deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In MaitlandADHDMedication studyAges 4–5
- Countries
- United States
- Sponsor
- Tris Pharma, Inc.
CompletedNCT00772161
Official study titleA Single-Center, Single-Blind, Randomized, Oral Dose Cross-Over Study in Prepuberal Boys With ADHD to Investigate Efficacy and Bioequivalence of 20 mg Ritalin LA Compared to 20 mg Medikinet Retard After Treatment With o.d. Doses Over 7 Days Each.
This study has finished and is no longer accepting participants.
In Freiburg im BreisgauADHDMedication studyAges 8–14
- Countries
- Germany
- Sponsor
- University Hospital Freiburg
CompletedNCT00556296
What is this study about?Researchers compared NRP104 and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 6–12
- Countries
- Sponsor
- New River Pharmaceuticals